|
21-30 |
31-40 |
41-50 |
51-60 |
61-70 |
Total, n (%) |
Proliferative endometrium |
2 |
23 |
22 |
6 |
0 |
53(35.4%) |
Disordered proliferative endometrium |
0 |
3 |
4 |
1 |
0 |
8(5.3%) |
Secretory endometrium |
1 |
11 |
12 |
0 |
0 |
24(16%) |
Endometrial hyperplasia without atypia |
0 |
4 |
7 |
6 |
1 |
18(12%) |
Endometrial hyperplasia with atypia |
0 |
2 |
3 |
2 |
0 |
7(4.7%) |
Atrophic endometrium |
0 |
0 |
0 |
2 (+1*) |
2 (+1*) |
4
(+2)(4%) |
Endometrial carcinoma |
0 |
0 |
1 |
1 |
3 |
5(3.3%) |
Chronic endometritis |
1 |
3 |
5 (+1*) |
2 |
0 |
11
(+1)(8%) |
Pill endometrium |
2 |
2 |
1 |
0 |
0 |
5(3.3%) |
Endometrial polyp |
1 |
3 |
2 |
1 |
1 |
8(5.3%) |
Inadequate sample |
0 |
2 |
3 (-1) |
1(-1) |
1(-1) |
7(-3
)(4.7%) |
Total |
7 |
53 |
60 |
22 |
8 |
150 |
Percentage (%) |
4.5 |
35.3 |
40.0 |
15 |
5.3 |
|